BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan M, Shong K, Li X, Ashraf S, Shi M, Kim W, Nielsen J, Turkez H, Shoaie S, Uhlen M, Zhang C, Mardinoglu A. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma. Cancers 2022;14:1573. [DOI: 10.3390/cancers14061573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan SA, Lee TKW. Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking. Front Pharmacol 2022;13:968148. [DOI: 10.3389/fphar.2022.968148] [Reference Citation Analysis]
2 Tatsumi S, Fujii T, Sugimoto A, Sekita-hatakeyama Y, Morita K, Uchiyama T, Itami H, Takeda M, Yamazaki M, Sho M, Ohbayashi C. Overexpression of microRNA-345 Affects the Invasive Capacity of Pancreatic Ductal Adenocarcinoma Cell Lines by Suppressing MUC1 and TJP2 Expression. Applied Sciences 2022;12:5351. [DOI: 10.3390/app12115351] [Reference Citation Analysis]